Watermark
  Back to Search Results

BGB-3111-213

Completed

BTK Inhibitor BGB-3111 in Chinese Participants With Diffuse Large B-Cell Lymphoma (Non-GCB) and Indolent Lymphoma (FL and MZL)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-213

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03520920

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20170965

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan